Report Cover

Global Biotechnological Drugs Market 2022 by Company, Regions, Type and Application, Forecast to 2028


The Biotechnological Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biotechnological Drugs market size is estimated to be worth US$  million in 2021 and is forecast to a readjusted size of USD  million by 2028 with a CAGR of  % during review period. Tumor accounting for  % of the Biotechnological Drugs global market in 2021, is projected to value USD  million by 2028, growing at a  % CAGR in next six years. While Genetically Engineered Drugs segment is altered to a  % CAGR between 2022 and 2028.
Global key companies of Biotechnological Drugs include 3SBIO, Anhui Anke Biotechnology, Beijing SL Pharmaceutical, Biotech Pharmaceutical, and Cadila Healthcare, etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Biotechnological Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Genetically Engineered Drugs
    Therapeutic Monoclonal Antibody Drugs
    Gene Therapy and Nucleic Acid Drugs
    Genetically Engineered Vaccines
    Other
Market segment by Application, can be divided into
    Tumor
    Autoimmune Disease
    Other
Market segment by players, this report covers
    3SBIO
    Anhui Anke Biotechnology
    Beijing SL Pharmaceutical
    Biotech Pharmaceutical
    Cadila Healthcare
    Celgen Biopharma
    Celltrion
    Dr Reddy's
    GeneScience Pharmaceuticals
    Hisun Pharma
    Jiangsu Sihuan Bioengineering
    Novartis (Sandoz)
    Pfizer (Hospira)
    Shanghai Lansheng Guojian Pharmaceutical
    Shenzhen Neptunus Interlong Bio-Technique
    Tonghua Dongbao Pharmaceutical
    Torrent Pharmaceuticals
Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biotechnological Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biotechnological Drugs, with revenue, gross margin and global market share of Biotechnological Drugs from 2019 to 2022.
Chapter 3, the Biotechnological Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biotechnological Drugs market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biotechnological Drugs research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Biotechnological Drugs
    1.2 Classification of Biotechnological Drugs by Type
        1.2.1 Overview: Global Biotechnological Drugs Market Size by Type: 2017 Versus 2021 Versus 2028
        1.2.2 Global Biotechnological Drugs Revenue Market Share by Type in 2021
        1.2.3 Genetically Engineered Drugs
        1.2.4 Therapeutic Monoclonal Antibody Drugs
        1.2.5 Gene Therapy and Nucleic Acid Drugs
        1.2.6 Genetically Engineered Vaccines
        1.2.7 Other
    1.3 Global Biotechnological Drugs Market by Application
        1.3.1 Overview: Global Biotechnological Drugs Market Size by Application: 2017 Versus 2021 Versus 2028
        1.3.2 Tumor
        1.3.3 Autoimmune Disease
        1.3.4 Other
    1.4 Global Biotechnological Drugs Market Size & Forecast
    1.5 Global Biotechnological Drugs Market Size and Forecast by Region
        1.5.1 Global Biotechnological Drugs Market Size by Region: 2017 VS 2021 VS 2028
        1.5.2 Global Biotechnological Drugs Market Size by Region, (2017-2022)
        1.5.3 North America Biotechnological Drugs Market Size and Prospect (2017-2028)
        1.5.4 Europe Biotechnological Drugs Market Size and Prospect (2017-2028)
        1.5.5 Asia-Pacific Biotechnological Drugs Market Size and Prospect (2017-2028)
        1.5.6 South America Biotechnological Drugs Market Size and Prospect (2017-2028)
        1.5.7 Middle East and Africa Biotechnological Drugs Market Size and Prospect (2017-2028)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Biotechnological Drugs Market Drivers
        1.6.2 Biotechnological Drugs Market Restraints
        1.6.3 Biotechnological Drugs Trends Analysis
2 Company Profiles
    2.1 3SBIO
        2.1.1 3SBIO Details
        2.1.2 3SBIO Major Business
        2.1.3 3SBIO Biotechnological Drugs Product and Solutions
        2.1.4 3SBIO Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.1.5 3SBIO Recent Developments and Future Plans
    2.2 Anhui Anke Biotechnology
        2.2.1 Anhui Anke Biotechnology Details
        2.2.2 Anhui Anke Biotechnology Major Business
        2.2.3 Anhui Anke Biotechnology Biotechnological Drugs Product and Solutions
        2.2.4 Anhui Anke Biotechnology Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.2.5 Anhui Anke Biotechnology Recent Developments and Future Plans
    2.3 Beijing SL Pharmaceutical
        2.3.1 Beijing SL Pharmaceutical Details
        2.3.2 Beijing SL Pharmaceutical Major Business
        2.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Product and Solutions
        2.3.4 Beijing SL Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.3.5 Beijing SL Pharmaceutical Recent Developments and Future Plans
    2.4 Biotech Pharmaceutical
        2.4.1 Biotech Pharmaceutical Details
        2.4.2 Biotech Pharmaceutical Major Business
        2.4.3 Biotech Pharmaceutical Biotechnological Drugs Product and Solutions
        2.4.4 Biotech Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.4.5 Biotech Pharmaceutical Recent Developments and Future Plans
    2.5 Cadila Healthcare
        2.5.1 Cadila Healthcare Details
        2.5.2 Cadila Healthcare Major Business
        2.5.3 Cadila Healthcare Biotechnological Drugs Product and Solutions
        2.5.4 Cadila Healthcare Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.5.5 Cadila Healthcare Recent Developments and Future Plans
    2.6 Celgen Biopharma
        2.6.1 Celgen Biopharma Details
        2.6.2 Celgen Biopharma Major Business
        2.6.3 Celgen Biopharma Biotechnological Drugs Product and Solutions
        2.6.4 Celgen Biopharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.6.5 Celgen Biopharma Recent Developments and Future Plans
    2.7 Celltrion
        2.7.1 Celltrion Details
        2.7.2 Celltrion Major Business
        2.7.3 Celltrion Biotechnological Drugs Product and Solutions
        2.7.4 Celltrion Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.7.5 Celltrion Recent Developments and Future Plans
    2.8 Dr Reddy's
        2.8.1 Dr Reddy's Details
        2.8.2 Dr Reddy's Major Business
        2.8.3 Dr Reddy's Biotechnological Drugs Product and Solutions
        2.8.4 Dr Reddy's Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.8.5 Dr Reddy's Recent Developments and Future Plans
    2.9 GeneScience Pharmaceuticals
        2.9.1 GeneScience Pharmaceuticals Details
        2.9.2 GeneScience Pharmaceuticals Major Business
        2.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Product and Solutions
        2.9.4 GeneScience Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.9.5 GeneScience Pharmaceuticals Recent Developments and Future Plans
    2.10 Hisun Pharma 
        2.10.1 Hisun Pharma Details
        2.10.2 Hisun Pharma Major Business
        2.10.3 Hisun Pharma Biotechnological Drugs Product and Solutions
        2.10.4 Hisun Pharma Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.10.5 Hisun Pharma Recent Developments and Future Plans
    2.11 Jiangsu Sihuan Bioengineering
        2.11.1 Jiangsu Sihuan Bioengineering Details
        2.11.2 Jiangsu Sihuan Bioengineering Major Business
        2.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Product and Solutions
        2.11.4 Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.11.5 Jiangsu Sihuan Bioengineering Recent Developments and Future Plans
    2.12 Novartis (Sandoz)
        2.12.1 Novartis (Sandoz) Details
        2.12.2 Novartis (Sandoz) Major Business
        2.12.3 Novartis (Sandoz) Biotechnological Drugs Product and Solutions
        2.12.4 Novartis (Sandoz) Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.12.5 Novartis (Sandoz) Recent Developments and Future Plans
    2.13 Pfizer (Hospira)
        2.13.1 Pfizer (Hospira) Details
        2.13.2 Pfizer (Hospira) Major Business
        2.13.3 Pfizer (Hospira) Biotechnological Drugs Product and Solutions
        2.13.4 Pfizer (Hospira) Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.13.5 Pfizer (Hospira) Recent Developments and Future Plans
    2.14 Shanghai Lansheng Guojian Pharmaceutical
        2.14.1 Shanghai Lansheng Guojian Pharmaceutical Details
        2.14.2 Shanghai Lansheng Guojian Pharmaceutical Major Business
        2.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product and Solutions
        2.14.4 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Developments and Future Plans
    2.15 Shenzhen Neptunus Interlong Bio-Technique
        2.15.1 Shenzhen Neptunus Interlong Bio-Technique Details
        2.15.2 Shenzhen Neptunus Interlong Bio-Technique Major Business
        2.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product and Solutions
        2.15.4 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Developments and Future Plans
    2.16 Tonghua Dongbao Pharmaceutical
        2.16.1 Tonghua Dongbao Pharmaceutical Details
        2.16.2 Tonghua Dongbao Pharmaceutical Major Business
        2.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product and Solutions
        2.16.4 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.16.5 Tonghua Dongbao Pharmaceutical Recent Developments and Future Plans
    2.17 Torrent Pharmaceuticals
        2.17.1 Torrent Pharmaceuticals Details
        2.17.2 Torrent Pharmaceuticals Major Business
        2.17.3 Torrent Pharmaceuticals Biotechnological Drugs Product and Solutions
        2.17.4 Torrent Pharmaceuticals Biotechnological Drugs Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
        2.17.5 Torrent Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Biotechnological Drugs Revenue and Share by Players (2019, 2020, 2021, and 2022)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Biotechnological Drugs Players Market Share in 2021
        3.2.2 Top 10 Biotechnological Drugs Players Market Share in 2021
        3.2.3 Market Competition Trend
    3.3 Biotechnological Drugs Players Head Office, Products and Services Provided
    3.4 Biotechnological Drugs Mergers & Acquisitions
    3.5 Biotechnological Drugs New Entrants and Expansion Plans
4 Market Size Segment by Type
    4.1 Global Biotechnological Drugs Revenue and Market Share by Type (2017-2022)
    4.2 Global Biotechnological Drugs Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
    5.1 Global Biotechnological Drugs Revenue Market Share by Application (2017-2022)
    5.2 Global Biotechnological Drugs Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
    6.1 North America Biotechnological Drugs Revenue by Type (2017-2028)
    6.2 North America Biotechnological Drugs Revenue by Application (2017-2028)
    6.3 North America Biotechnological Drugs Market Size by Country
        6.3.1 North America Biotechnological Drugs Revenue by Country (2017-2028)
        6.3.2 United States Biotechnological Drugs Market Size and Forecast (2017-2028)
        6.3.3 Canada Biotechnological Drugs Market Size and Forecast (2017-2028)
        6.3.4 Mexico Biotechnological Drugs Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
    7.1 Europe Biotechnological Drugs Revenue by Type (2017-2028)
    7.2 Europe Biotechnological Drugs Revenue by Application (2017-2028)
    7.3 Europe Biotechnological Drugs Market Size by Country
        7.3.1 Europe Biotechnological Drugs Revenue by Country (2017-2028)
        7.3.2 Germany Biotechnological Drugs Market Size and Forecast (2017-2028)
        7.3.3 France Biotechnological Drugs Market Size and Forecast (2017-2028)
        7.3.4 United Kingdom Biotechnological Drugs Market Size and Forecast (2017-2028)
        7.3.5 Russia Biotechnological Drugs Market Size and Forecast (2017-2028)
        7.3.6 Italy Biotechnological Drugs Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Biotechnological Drugs Revenue by Type (2017-2028)
    8.2 Asia-Pacific Biotechnological Drugs Revenue by Application (2017-2028)
    8.3 Asia-Pacific Biotechnological Drugs Market Size by Region
        8.3.1 Asia-Pacific Biotechnological Drugs Revenue by Region (2017-2028)
        8.3.2 China Biotechnological Drugs Market Size and Forecast (2017-2028)
        8.3.3 Japan Biotechnological Drugs Market Size and Forecast (2017-2028)
        8.3.4 South Korea Biotechnological Drugs Market Size and Forecast (2017-2028)
        8.3.5 India Biotechnological Drugs Market Size and Forecast (2017-2028)
        8.3.6 Southeast Asia Biotechnological Drugs Market Size and Forecast (2017-2028)
        8.3.7 Australia Biotechnological Drugs Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
    9.1 South America Biotechnological Drugs Revenue by Type (2017-2028)
    9.2 South America Biotechnological Drugs Revenue by Application (2017-2028)
    9.3 South America Biotechnological Drugs Market Size by Country
        9.3.1 South America Biotechnological Drugs Revenue by Country (2017-2028)
        9.3.2 Brazil Biotechnological Drugs Market Size and Forecast (2017-2028)
        9.3.3 Argentina Biotechnological Drugs Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Biotechnological Drugs Revenue by Type (2017-2028)
    10.2 Middle East & Africa Biotechnological Drugs Revenue by Application (2017-2028)
    10.3 Middle East & Africa Biotechnological Drugs Market Size by Country
        10.3.1 Middle East & Africa Biotechnological Drugs Revenue by Country (2017-2028)
        10.3.2 Turkey Biotechnological Drugs Market Size and Forecast (2017-2028)
        10.3.3 Saudi Arabia Biotechnological Drugs Market Size and Forecast (2017-2028)
        10.3.4 UAE Biotechnological Drugs Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

List of Tables Table 1. Global Biotechnological Drugs Revenue by Type, (USD Million), 2017 VS 2021 VS 2028 Table 2. Global Biotechnological Drugs Revenue by Application, (USD Million), 2017 VS 2021 VS 2028 Table 3. Global Market Biotechnological Drugs Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028) Table 4. Global Biotechnological Drugs Revenue (USD Million) by Region (2017-2022) Table 5. Global Biotechnological Drugs Revenue Market Share by Region (2023-2028) Table 6. 3SBIO Corporate Information, Head Office, and Major Competitors Table 7. 3SBIO Major Business Table 8. 3SBIO Biotechnological Drugs Product and Solutions Table 9. 3SBIO Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 10. Anhui Anke Biotechnology Corporate Information, Head Office, and Major Competitors Table 11. Anhui Anke Biotechnology Major Business Table 12. Anhui Anke Biotechnology Biotechnological Drugs Product and Solutions Table 13. Anhui Anke Biotechnology Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 14. Beijing SL Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 15. Beijing SL Pharmaceutical Major Business Table 16. Beijing SL Pharmaceutical Biotechnological Drugs Product and Solutions Table 17. Beijing SL Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 18. Biotech Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 19. Biotech Pharmaceutical Major Business Table 20. Biotech Pharmaceutical Biotechnological Drugs Product and Solutions Table 21. Biotech Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 22. Cadila Healthcare Corporate Information, Head Office, and Major Competitors Table 23. Cadila Healthcare Major Business Table 24. Cadila Healthcare Biotechnological Drugs Product and Solutions Table 25. Cadila Healthcare Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 26. Celgen Biopharma Corporate Information, Head Office, and Major Competitors Table 27. Celgen Biopharma Major Business Table 28. Celgen Biopharma Biotechnological Drugs Product and Solutions Table 29. Celgen Biopharma Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 30. Celltrion Corporate Information, Head Office, and Major Competitors Table 31. Celltrion Major Business Table 32. Celltrion Biotechnological Drugs Product and Solutions Table 33. Celltrion Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 34. Dr Reddy's Corporate Information, Head Office, and Major Competitors Table 35. Dr Reddy's Major Business Table 36. Dr Reddy's Biotechnological Drugs Product and Solutions Table 37. Dr Reddy's Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 38. GeneScience Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 39. GeneScience Pharmaceuticals Major Business Table 40. GeneScience Pharmaceuticals Biotechnological Drugs Product and Solutions Table 41. GeneScience Pharmaceuticals Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 42. Hisun Pharma Corporate Information, Head Office, and Major Competitors Table 43. Hisun Pharma Major Business Table 44. Hisun Pharma Biotechnological Drugs Product and Solutions Table 45. Hisun Pharma Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 46. Jiangsu Sihuan Bioengineering Corporate Information, Head Office, and Major Competitors Table 47. Jiangsu Sihuan Bioengineering Major Business Table 48. Jiangsu Sihuan Bioengineering Biotechnological Drugs Product and Solutions Table 49. Jiangsu Sihuan Bioengineering Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 50. Novartis (Sandoz) Corporate Information, Head Office, and Major Competitors Table 51. Novartis (Sandoz) Major Business Table 52. Novartis (Sandoz) Biotechnological Drugs Product and Solutions Table 53. Novartis (Sandoz) Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 54. Pfizer (Hospira) Corporate Information, Head Office, and Major Competitors Table 55. Pfizer (Hospira) Major Business Table 56. Pfizer (Hospira) Biotechnological Drugs Product and Solutions Table 57. Pfizer (Hospira) Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 58. Shanghai Lansheng Guojian Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 59. Shanghai Lansheng Guojian Pharmaceutical Major Business Table 60. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Product and Solutions Table 61. Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 62. Shenzhen Neptunus Interlong Bio-Technique Corporate Information, Head Office, and Major Competitors Table 63. Shenzhen Neptunus Interlong Bio-Technique Major Business Table 64. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Product and Solutions Table 65. Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 66. Tonghua Dongbao Pharmaceutical Corporate Information, Head Office, and Major Competitors Table 67. Tonghua Dongbao Pharmaceutical Major Business Table 68. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Product and Solutions Table 69. Tonghua Dongbao Pharmaceutical Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 70. Torrent Pharmaceuticals Corporate Information, Head Office, and Major Competitors Table 71. Torrent Pharmaceuticals Major Business Table 72. Torrent Pharmaceuticals Biotechnological Drugs Product and Solutions Table 73. Torrent Pharmaceuticals Biotechnological Drugs Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022) Table 74. Global Biotechnological Drugs Revenue (USD Million) by Players (2019, 2020, 2021, and 2022) Table 75. Global Biotechnological Drugs Revenue Share by Players (2019, 2020, 2021, and 2022) Table 76. Breakdown of Biotechnological Drugs by Company Type (Tier 1, Tier 2 and Tier 3) Table 77. Biotechnological Drugs Players Head Office, Products and Services Provided Table 78. Biotechnological Drugs Mergers & Acquisitions in the Past Five Years Table 79. Biotechnological Drugs New Entrants and Expansion Plans Table 80. Global Biotechnological Drugs Revenue (USD Million) by Type (2017-2022) Table 81. Global Biotechnological Drugs Revenue Share by Type (2017-2022) Table 82. Global Biotechnological Drugs Revenue Forecast by Type (2023-2028) Table 83. Global Biotechnological Drugs Revenue by Application (2017-2022) Table 84. Global Biotechnological Drugs Revenue Forecast by Application (2023-2028) Table 85. North America Biotechnological Drugs Revenue by Type (2017-2022) & (USD Million) Table 86. North America Biotechnological Drugs Revenue by Type (2023-2028) & (USD Million) Table 87. North America Biotechnological Drugs Revenue by Application (2017-2022) & (USD Million) Table 88. North America Biotechnological Drugs Revenue by Application (2023-2028) & (USD Million) Table 89. North America Biotechnological Drugs Revenue by Country (2017-2022) & (USD Million) Table 90. North America Biotechnological Drugs Revenue by Country (2023-2028) & (USD Million) Table 91. Europe Biotechnological Drugs Revenue by Type (2017-2022) & (USD Million) Table 92. Europe Biotechnological Drugs Revenue by Type (2023-2028) & (USD Million) Table 93. Europe Biotechnological Drugs Revenue by Application (2017-2022) & (USD Million) Table 94. Europe Biotechnological Drugs Revenue by Application (2023-2028) & (USD Million) Table 95. Europe Biotechnological Drugs Revenue by Country (2017-2022) & (USD Million) Table 96. Europe Biotechnological Drugs Revenue by Country (2023-2028) & (USD Million) Table 97. Asia-Pacific Biotechnological Drugs Revenue by Type (2017-2022) & (USD Million) Table 98. Asia-Pacific Biotechnological Drugs Revenue by Type (2023-2028) & (USD Million) Table 99. Asia-Pacific Biotechnological Drugs Revenue by Application (2017-2022) & (USD Million) Table 100. Asia-Pacific Biotechnological Drugs Revenue by Application (2023-2028) & (USD Million) Table 101. Asia-Pacific Biotechnological Drugs Revenue by Region (2017-2022) & (USD Million) Table 102. Asia-Pacific Biotechnological Drugs Revenue by Region (2023-2028) & (USD Million) Table 103. South America Biotechnological Drugs Revenue by Type (2017-2022) & (USD Million) Table 104. South America Biotechnological Drugs Revenue by Type (2023-2028) & (USD Million) Table 105. South America Biotechnological Drugs Revenue by Application (2017-2022) & (USD Million) Table 106. South America Biotechnological Drugs Revenue by Application (2023-2028) & (USD Million) Table 107. South America Biotechnological Drugs Revenue by Country (2017-2022) & (USD Million) Table 108. South America Biotechnological Drugs Revenue by Country (2023-2028) & (USD Million) Table 109. Middle East & Africa Biotechnological Drugs Revenue by Type (2017-2022) & (USD Million) Table 110. Middle East & Africa Biotechnological Drugs Revenue by Type (2023-2028) & (USD Million) Table 111. Middle East & Africa Biotechnological Drugs Revenue by Application (2017-2022) & (USD Million) Table 112. Middle East & Africa Biotechnological Drugs Revenue by Application (2023-2028) & (USD Million) Table 113. Middle East & Africa Biotechnological Drugs Revenue by Country (2017-2022) & (USD Million) Table 114. Middle East & Africa Biotechnological Drugs Revenue by Country (2023-2028) & (USD Million) List of Figures Figure 1. Biotechnological Drugs Picture Figure 2. Global Biotechnological Drugs Revenue Market Share by Type in 2021 Figure 3. Genetically Engineered Drugs Figure 4. Therapeutic Monoclonal Antibody Drugs Figure 5. Gene Therapy and Nucleic Acid Drugs Figure 6. Genetically Engineered Vaccines Figure 7. Other Figure 8. Biotechnological Drugs Revenue Market Share by Application in 2021 Figure 9. Tumor Picture Figure 10. Autoimmune Disease Picture Figure 11. Other Picture Figure 12. Global Biotechnological Drugs Market Size, (USD Million): 2017 VS 2021 VS 2028 Figure 13. Global Biotechnological Drugs Revenue and Forecast (2017-2028) & (USD Million) Figure 14. Global Biotechnological Drugs Revenue Market Share by Region (2017-2028) Figure 15. Global Biotechnological Drugs Revenue Market Share by Region in 2021 Figure 16. North America Biotechnological Drugs Revenue (USD Million) and Growth Rate (2017-2028) Figure 17. Europe Biotechnological Drugs Revenue (USD Million) and Growth Rate (2017-2028) Figure 18. Asia-Pacific Biotechnological Drugs Revenue (USD Million) and Growth Rate (2017-2028) Figure 19. South America Biotechnological Drugs Revenue (USD Million) and Growth Rate (2017-2028) Figure 20. Middle East and Africa Biotechnological Drugs Revenue (USD Million) and Growth Rate (2017-2028) Figure 21. Biotechnological Drugs Market Drivers Figure 22. Biotechnological Drugs Market Restraints Figure 23. Biotechnological Drugs Market Trends Figure 24. 3SBIO Recent Developments and Future Plans Figure 25. Anhui Anke Biotechnology Recent Developments and Future Plans Figure 26. Beijing SL Pharmaceutical Recent Developments and Future Plans Figure 27. Biotech Pharmaceutical Recent Developments and Future Plans Figure 28. Cadila Healthcare Recent Developments and Future Plans Figure 29. Celgen Biopharma Recent Developments and Future Plans Figure 30. Celltrion Recent Developments and Future Plans Figure 31. Dr Reddy's Recent Developments and Future Plans Figure 32. GeneScience Pharmaceuticals Recent Developments and Future Plans Figure 33. Hisun Pharma Recent Developments and Future Plans Figure 34. Jiangsu Sihuan Bioengineering Recent Developments and Future Plans Figure 35. Novartis (Sandoz) Recent Developments and Future Plans Figure 36. Pfizer (Hospira) Recent Developments and Future Plans Figure 37. Shanghai Lansheng Guojian Pharmaceutical Recent Developments and Future Plans Figure 38. Shenzhen Neptunus Interlong Bio-Technique Recent Developments and Future Plans Figure 39. Tonghua Dongbao Pharmaceutical Recent Developments and Future Plans Figure 40. Torrent Pharmaceuticals Recent Developments and Future Plans Figure 41. Global Biotechnological Drugs Revenue Share by Players in 2021 Figure 42. Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021 Figure 43. Global Top 3 Players Biotechnological Drugs Revenue Market Share in 2021 Figure 44. Global Top 10 Players Biotechnological Drugs Revenue Market Share in 2021 Figure 45. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022) Figure 46. Global Biotechnological Drugs Revenue Share by Type in 2021 Figure 47. Global Biotechnological Drugs Market Share Forecast by Type (2023-2028) Figure 48. Global Biotechnological Drugs Revenue Share by Application in 2021 Figure 49. Global Biotechnological Drugs Market Share Forecast by Application (2023-2028) Figure 50. North America Biotechnological Drugs Sales Market Share by Type (2017-2028) Figure 51. North America Biotechnological Drugs Sales Market Share by Application (2017-2028) Figure 52. North America Biotechnological Drugs Revenue Market Share by Country (2017-2028) Figure 53. United States Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 54. Canada Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 55. Mexico Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 56. Europe Biotechnological Drugs Sales Market Share by Type (2017-2028) Figure 57. Europe Biotechnological Drugs Sales Market Share by Application (2017-2028) Figure 58. Europe Biotechnological Drugs Revenue Market Share by Country (2017-2028) Figure 59. Germany Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 60. France Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 61. United Kingdom Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 62. Russia Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 63. Italy Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 64. Asia-Pacific Biotechnological Drugs Sales Market Share by Type (2017-2028) Figure 65. Asia-Pacific Biotechnological Drugs Sales Market Share by Application (2017-2028) Figure 66. Asia-Pacific Biotechnological Drugs Revenue Market Share by Region (2017-2028) Figure 67. China Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 68. Japan Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 69. South Korea Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 70. India Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 71. Southeast Asia Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 72. Australia Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 73. South America Biotechnological Drugs Sales Market Share by Type (2017-2028) Figure 74. South America Biotechnological Drugs Sales Market Share by Application (2017-2028) Figure 75. South America Biotechnological Drugs Revenue Market Share by Country (2017-2028) Figure 76. Brazil Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 77. Argentina Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 78. Middle East and Africa Biotechnological Drugs Sales Market Share by Type (2017-2028) Figure 79. Middle East and Africa Biotechnological Drugs Sales Market Share by Application (2017-2028) Figure 80. Middle East and Africa Biotechnological Drugs Revenue Market Share by Country (2017-2028) Figure 81. Turkey Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 82. Saudi Arabia Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 83. UAE Biotechnological Drugs Revenue and Growth Rate (2017-2028) & (USD Million) Figure 84. Methodology Figure 85. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us